US Edition
Ocugen to Showcase Gene Therapy Advancements at 2025 BIO International Convention
Summary by MyChesCo
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
All
Left
Center
Right
Ocugen to Showcase Gene Therapy Advancements at 2025 BIO International Convention
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) announced its participation in the 2025 BIO International Convention, held from June 16-19 at the Boston Convention & Exhibition Center. The biopharmaceutical company will highlight its novel modifier gene therapy platform, designed as a potential one-time treatment for major blindness diseases, while exploring new partnership opportunities. During the convention, Ocugen’s leadership will meet with pharm…
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
